Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 1025-1030

  Shah, Punit P ^a   Mashru, Rajashree C ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Cachets; Cyclodextrin; Primaquine phosphate; Taste masking

Indexed keywords

BETA CYCLODEXTRIN; PRIMAQUINE;

ARTICLE; BITTER TASTE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROPHILICITY; INFRARED SPECTROSCOPY; MALE; MASKING; NORMAL HUMAN; PH; PHYSICAL CHEMISTRY; SUSPENSION; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; ADULT; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MALE; PHARMACEUTICAL SOLUTIONS; PRIMAQUINE; SOLUBILITY; TASTE PERCEPTION; YOUNG ADULT;

EID: 57249097186     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9137-6     Document Type: Article

References (21)

1. D. Bhadra, A. K. Yadav, S. Bhadra, and N. K. Jain. Glycodendrimeric nanopartiulate carriers of primaquine phosphate for liver targeting. Int. J. Pharm. 295: 221-233 (2005).
2. T. Yamamoto, T. Nagai, T. Shimura, and Y. Yasoshima. Roles of chemical mediators in taste system. Jpn. J. Pharmacol. 76: 325-348 (1998).
3. J. Barra, F. Lescure, and E. Doelker. Taste masking as a consequence of the organisation of powder mixes. Pharm. Acta. Helv. 74: 37-42 (1999).
4. R. Chopra, G. Alderborn, J. M. Newton, and F. Podezeck. The influence of film coating on pellet properties. Pharm. Dev. Tech. 7: 59-68 (2002).
5. T. Jaskari, M. Vuorio, K. Kontturi, J. A. Manzanares, and J. Hirvonen. Ion-exchange fibers and drugs: An equilibrium study. J. Contr. Release. 70: 219-229 (2001).
6. M. Vuorio, J. A. Manzanares, L. Murtomaki, J. Hirvonen, T. Kankkunen, and K. Kontturi. Ion exchange fibers and drugs: A transient study. J. Contr. Release. 91: 439-448 (2003).
7. S. Borodkin, and M. H. Yunker. Interaction of amine drugs with a polycarboxylic acid ion-exchange resin. J. Pharm. Sci. 59: 481-485 (1970).
8. A. H. Vyas, C. V. Bhat, B. R. Kamath, and S. L. Bafna. Cinchona alkaloids on ion-exchange resins V: Ammonium form of resins. J. Pharm. Sci. 62: 1386-1387 (1973).
9. I. Seiyaku. Inclusion compounds of tiaramide or its acid addition salts. JP 56061369.1981.
10. K. Freudenberg, F. Cramer, and H. Plieninger, Inclusion compounds of physiologically active organic compounds. Germ. Pat. 895769, (1953).
11. J. Toda, M. Misaki, A. Konno, T. Wada, and K. Yasumatsu. Interaction of cyclodextrins with taste substances. In G. Inglett (eds.), Proceedings of the 2nd Int. Flavour Conference. Vol. 1, Academic, New York, 1985, pp. 19-35.
12. J. Szejtli, and L. Szente. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur. J. Pharm. Biopharm. 61: 115-125 (2005).
13. T. Higuchi, and K. A. Connors. Phase-solubility techniques. Adv. Anal. Chem. Instr. 4: 117-212 (1965).
14. V. R. Sinha, R. Anitha, S. Ghosh, A. Nanda, and R. Kumaria. Complexation of celecoxib with b-cyclodextrin: Characterization of the interaction in solution and in solid state. J. Pharm. Sci. 94: 676-687 (2005).
15. A. Modi, and P. Tayade. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS Pharm. Sci. Tech. 7:aRticle 68 (2006).
16. F. L. Mou-ying, B. Saul, W. Linda, L. Ping, C. Diesner, L. Hernandez, and M. A. Vadnere. polymeric carrier system for taste masking of macrolide antibiotics. Pharm. Res. 8: 706-712 (1991).
17. N. Li, Y.-H. Zhang, Y.-N. Wu, X.-L. Xiong, and Y.-H. Zhang. Inclusion complex of trimethoprim with beta-cyclodextrin. J. Pharm. Biomed. Anal. 39: 824-829 (2005).
18. J. Mielcarek, A. Czernielewska, and B. Czarczynska. Inclusion complexes of felodipine and amlodipine with methyl-beta-cyclodextrin. J. Inclus. Phenom. Macro. Chem. 54: 17-21 (2006).
19. N. B. Naidu, K. P. R. Chowdary, K. V. R. Murthy, V. Satyananarayana, A. R. Hayman, and G. Becket. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. J. Pharm. Biomed. Anal. 35: 75-86 (2004).
20. P. Mura, M. T. Faucci, F. Maestrelli, S. Furlanetto, and S. Pinzauti. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers. J. Pharm. Biomed. Anal. 29: 1015-1024 (2002).
21. F. J. Otero-Espinar, S. Anguiano-Igea, N. G. Gonzalez, J. L. Vila-Jato, and J. Blanco-Mendez. Oral bioavailability of naproxen-b-cyclodextrin inclusion compound. Int. J. Pharm. 75: 37-44 (1991).